Vivid Visions Optometry, Inc.
27201 Tourney Rd., Suite 100 Valencia, CA 91355
(661) 310-0603
www.vividvisionsoptometry.com

Myopia, also known as nearsightedness, occurs when the eye grows too long from front to back. When this happens, light focuses in front of the retina instead of directly on it, causing distant objects to appear blurry.

The exact cause of myopia is not fully understood. However, research suggests that bothenvironmental and genetic factors play a role. Environmental factors may include limited time spentoutdoors and increased amounts of near work, such as reading or screen use. Genetics alsocontribute, as children with one or both parents who have myopia are more likely to develop myopiathemselves.

Myopia is becoming increasingly common worldwide. It is estimated that approximately 50% ofthe global population may have myopia by the year 2050.

 

Myopia Progression

In many children, the degree of myopia increases over time as the eyes continue to grow. Thisprogression most commonly occurs between the ages of 9 and 18, although some children maydevelop myopia at a younger age or experience faster-than-average progression.

 

Risks Associated with Myopia

Myopia is associated with an increased risk of developing certain eye diseases later in life, includingretinal detachment, cataracts, macular degeneration, and glaucoma. In general, the higher thelevel of myopia, the greater the risk of these conditions. For this reason, there is strong clinicalinterest in slowing the progression of myopia during childhood.

Evidence in the scientific literature suggests that certain optical designs may help slow theprogression of nearsightedness (myopia) in children. Myopia control treatments are intended to slowthe rate of myopia progression. They do not reverse myopia, eliminate the need for glasses or contactlenses, or guarantee a specific outcome. Individual results vary. There are two FDA-approved myopia control methods offered in this Myopia Control Clinic. Each has its own benefits and limitations. Your child’s recommended treatment(s) will be marked bythe doctor

MiSight 1 Day contact lenses are soft, daily disposable contact lenses worn during waking hours and discarded each day. They are designed with a dual-focus optical system that provides clear distance vision while delivering a treatment signal intended to slow myopia progression. For optimal effectiveness, MiSight lenses must be worn for a minimum of 10 hours per day and at least 6 days per week, unless otherwise directed by the doctor. MiSight lenses look and feel similar to regular contact lenses. Some children may notice slightly different visual clarity compared to standard single-vision contact lenses, particularly during the initial adaptation period. There are no additional risks beyond those associated with regular daily disposable contact lens wear when proper hygiene and wear instructions are followed. MiSight 1 Day is currently the only FDA-approved contact lens for myopia control in the United States.

Stellest lenses are myopia control eyeglass lenses that look and function like regular glasses. They provide clear central vision for everyday activities and contain specialized lens segments designed to guide how light focuses in the eye, creating a signal intended to slow myopia progression. For optimal effectiveness, Stellest lenses must be worn for a minimum of 10 hours per day and at least 6 days per week, unless otherwise directed by the doctor. Children typically adapt well to Stellest lenses. As with any new glasses, a short adaptation period may occur. Stellest lenses are worn full time as prescribed. Stellest is currently the only FDA-approved spectacle lens for myopia control in the United States.

I understand that enrollment in the Myopia Control Program requires payment of a yearly program fee, which covers a 12-month treatment period.
The annual program fee includes:

• Professional myopia control evaluation and treatment planning
• A required follow-up visit 2 to 4 weeks after starting treatment
• A required follow-up visit approximately 6 months after starting treatment

I understand that continued myopia control treatment beyond the initial 12-month period requires payment of a new annual program fee.
I understand that material fees are separate and are not included in the program fee. Material fees may include, but are not limited to:

• MiSight contact lenses
• Stellest spectacle lenses
• Replacement lenses or additional supplies

I understand that attendance at follow-up visits is required. Failure to attend scheduled follow-up visits may reduce treatment effectiveness and limit the doctor's ability to properly monitor my child's eye health and myopia progression.

I understand and agree to the following financial terms:

• The Myopia Control Program fee is charged annually and is due at the time of enrollment.
• The program fee covers professional services only and does not include the cost of lenses, contact lenses, or other materials.
• Material fees are billed separately and are due at the time materials are ordered or dispensed.
• The annual program fee is non-refundable, regardless of treatment outcome, compliance, or discontinuation of treatment.
• Missed appointments, late cancellations, or failure to attend required follow-up visits do not result in refunds or credits.
• Insurance typically does not cover myopia control services. I understand that I am financially responsible for all charges not covered by insurance, if applicable.

• I understand that myopia control treatments aim to slow progression, not stop or reverse nearsightedness.
• I understand that there is no guarantee or assurance of a specific treatment outcome.
• I understand that my child may still experience myopia progression despite treatment.
• I understand that the prescribed correction (MiSight contact lenses or Stellest spectacle lenses) must be worn for a minimum of 10 hours per day and at least 6 days per week for treatment to be effective.
• I understand that failure to meet required wear time may reduce or eliminate treatment effectiveness.
• I understand that consistent wear time, program compliance, and scheduled follow-up visits are essential for treatment success.

 

By signing below, I acknowledge that I have read and understand this informed consent and financial agreement. All questions have been answered to my satisfaction, and I agree to the terms outlined above.